`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`LUPIN, LTD. and LUPIN PHARMACEUTICALS, INC.,
`Petitioner
`
`
`
`v.
`
`
`
`HYPERION THERAPEUTICS INC.,
`Patent Owner
`
`
`
`IPR2016-00283
`IPR2016-00284
`
`
`
`U.S. PATENTS 8,642,012 and 8,404,215
`
`
`
`LUPIN, LTD.’S POWER OF ATTORNEY
`
`
`
`
`
`Mail Stop “PATENT BOARD” Patent Trial and Appeal Board
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`§’§*Z’”§’§V‘”§7%.{}§%鑧'~‘Zi,§ §’f}W§:Z§?; SE?
`
`§3<;:i:it§<)m:1‘ .i.L.1u;>inA.§ Ltd. §és;::‘:::by ::p;;~m°zi:&: :§“:::: §1;3§EGwEr:g;j;3:“a.c§é*£‘icm<::%:‘s; zlsssmséssteci
`
`wizh {mzzadwin ?1”<‘2{:¥;s2‘ §.;§..P as: fix £:tfi:>m<:jgs; is irzmzezaci 21%? bii§S§.i}.ii§§E3 in iihzi {.§%:1%i£:d
`
`f:§E.at::::’:s §E’:;1§8m: smii Trz3;{%e:*:’}2z:*§<:. {:}:“f‘":<::: zzagacézxéad ‘mil: :Ts2:::;= ;3(zi”?::€S anzzwicéws aim“ {$3.33.
`
`§7‘:m:m
`
`8i>ii2,{3i2 ;m<;i 8,<é{}:?,2E5:
`
`
`
`§ §3;;c§<;-::§: §f.?wnV$e§ ”
`
`2: E..zm':%>é3¥€
`irL*3::*4§m;;:n.
`Ll'ymi*1i
`R
`E\§c>. 333.} E 79}
`f.
`<3(I}{}§:)W§.N §f’¥l_{}C§”if¥;Z§%. §,.L.§’
`
`"{‘h~:.-3 New “x”c»:‘i{ Téixleg: §§1i§{§§1’1§f_;§
`£;’:>IiZ(} Li§:T§gk.ih z\v:‘~:m.1£3
`§§\En=::w Y<i>:”§~:?
`E{}{}E §%«i4€}§
`l
`am...
`1ar:fi:"nan{§}§2g<}0cfi'W§1”a§>:'<:>a::%‘a;a2'.C:;>m
`§7L§”::i: ?.12-4:S§~?2?35
`§F2?2x:
`2'1 2~3:’.§5~333E3
`
`........
`
` H
`
`A
`V
`E32‘. £.,%1:f13 Pa? f:%m§;§h
`S:::::’1§€2r Vica .E“;‘€::%ida:m
`
`figs:
`
`::.»::>§%
`
`J E
`
`fiy:
`գԎ2ame:::
`
`"?§‘:,i::::
`
`Ei}:§ét::
`
`E Ei
`
`; EiI2=zEs %
`
`I igmzci ifmmfiéei
`
`§Ei’§i;zaV§3eiif1 J. §i<?:vIE;1§::<i
`
`fiisg. N0. »¢’W,{{sf3’?)
`<3(}(f.}§WiZ‘~é P§%{i)iCZ"¥5’§§R. {L9
`
`fizz: N«:«:w ‘{<:arE< ‘éime/3 Euiédiaxgg
`$20 Eigiath .s‘3.*«;~':311m;3
`?::w "‘:’<;§Lr%<, §‘~§\“' H}i’}%?§~1*~’E~€35
`%i;‘h{}H
`zmé «:f:f§§{§igac;-<iwi;x p1*c>cL:s::*.a:at):*2:1
`62: 212—45§3—?23{3
`
`
`
`i $
`
`2E
`
`%i7:;:x: 2i'Zi~«3:35-3333